The microarray industry continues to shift focus from research and development tools towards different applications in various areas such as drug discovery, clinical diagnostics, and sequencing. Major applications of the technology lie in gene expression, cancer diagnosis and treatment, SNP genotyping, genomics, agricultural biotechnology, drug discovery, and proteomics. In future advances in microarray technology helping in disease diagnosis and drug response are expected to have a high impact on the market growth. Microarrays have also been successfully applied in a variety of other areas such as toxicogneomics, environmental sciences, biodefense, agriculture research, veterinary and forensics.

global-array-instruments-market

The global array instruments market can be categorized into technologies, end-users and geography. DNA microarray is the prime and traditional microarray technology. Availability of a wide range of instruments for DNA microarray analysis and their efficacy in both research and drug discovery are the major factors driving the demand for microarray instruments. DNA microarray technology accounts for around 50% of the total array instruments market. It is expected that the global market for DNA microarray will grow at a CAGR of 3.9% from 2014 to 2019.

Technological advancements in fluorescent labeling and detection methods have offered significant advantage in data, quality, speed, and user safety for microarray based assays. This has enabled microarray based genomic technologies to revolutionize genetic analysis of biologic systems and the widespread routine use of these genomic technologies. Disease diagnosis and identification and research and drug discovery are the two prime application areas of microarray instruments. Thus in terms of end-users, research and development segment is expected to dominate the global array instruments market during the given period of forecast. Use of CytoScanHD microarray technology designed by Affymetrix has helped in searching millions of chromosomes and unique pattern in the cancer cells of leukemia patients. This new approach may be a sign of new revolution in diagnosis and treatment of cancer. Lack of efficient data analysis tools and the lack of expertise in microarray coupled with expensive nature of technology, is expected to be a significant restraint until local entities do not introduce similar technologies at lower cost.

Geographically, North America is the dominant regional market for array instruments with almost half of the market share, followed by Europe accounting for around 30% share. The array instrument market in North America was valued at USD 417.4 million in 2014 and is expected to reach USD 526.4 million by 2020. Emerging countries of Asia-Pacific, Latin America and Middle-East are expected to undergo rapid market growth by 2020. Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel market growth in these regions. Identification of genomic differences to predict drug resistance or drug response by patients may offer scope to design a customized therapy tailored to the specific characteristics of a particular cancer. Further exploration in the field of microarray analysis may also assist in developing preventive, regenerative and personalized and targeted therapy for other difficult-to-treat diseases of the central nervous system and vital organs.

Recent studies have demonstrated success of glycan arrays for high throughput elucidation of interactions between different carbohydrates and biological targets, such as proteins, viruses, cells and antibodies. One of the major advantages associated with glycan array analysis compared to traditional methods is multivalent display of arrayed glycans mimicking the real cell surface display. The array instruments market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Microarray technology is dominated by few major players such as Affymetrix, Inc. Illumina, Inc., Agilent Technologies and Molecular Devices contributing to around 80% of the total market. Other players in the array instruments market include Bio-Rad Laboratories, Thermo Fischer Scientific, ArrayJet Ltd and Sigma Aldrich Corporation.

Browse the full Array Instruments Market (Technologies: DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays; End Users: Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Forensic Centers, Veterinary Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020 report at http://www.transparencymarketresearch.com/global-array-market.html

The global array instruments market is segmented as follows:

Array Instruments Market, by Technology
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Array Instruments Market, by End-Users
Research and Development Laboratories
Clinical Diagnostic Labs
Agriculture Research Centers
Veterinary Laboratories
Forensic Centers
Array Instruments Market, by Geography
North America
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Europe
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Asia-Pacific
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Rest of the World (RoW)
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=495